Skip to main content

Phreesia, Inc.

PHR
Exchange
NYSE
Industry
Services-Business Services, NEC
SEC CIK
0001412408

In the last 90 days, Phreesia, Inc. insiders filed 0 open-market purchases and 4 sales; 227 institutions reported holding it in 13F filings for Q2 2026, worth $598.3M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Phreesia, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
4 filings
3 insiders, $101.4K in total
Insiders trading
3
Net value
−$101.4K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Phreesia, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Phreesia, Inc.
NameTitleLast reported holdingLast filingFilings, past year
VanDuyn Amy BethSVP, Human Resources260,521Sep 22, 202610
Roberts EvanPresident, Provider Solutions1,038,138Sep 22, 202610
Linetsky DavidPresident, Network Solutions22,267IndirectSep 22, 202615
Hoffman Allison CGeneral Counsel & Secretary266,574Sep 22, 202613
Indig ChaimChief Executive Officer1,889,595Sep 3, 20267
Hui YvonnePrincipal Accounting Officer64,724Sep 3, 202614
Gandhi BalajiChief Financial Officer348,931Sep 3, 20268
Munson GillianDirector66,789Aug 3, 20265
Goldstein LainieDirector70,862Aug 3, 20265
Egbuonu-Davis LisaDirector37,780Jul 16, 20262
Kessler JonDirector43,884Jun 26, 20262
Smith Mark DouglasDirector56,643Jun 26, 20261
Sayar RaminDirector52,725Jun 26, 20261
Cahill Edward LDirector65,613May 4, 20263
Barta Jan10% Owner8,924,329IndirectApr 2, 20262
Pale Fire Capital SE10% Owner8,924,329IndirectApr 2, 20262
Senkypl Dusan10% Owner8,924,329IndirectApr 2, 20262
Pale Fire Capital SICAV a.s.10% Owner8,924,329IndirectApr 2, 20262
Pale Fire Capital investicni spolecnost a.s.10% Owner8,924,329IndirectApr 2, 20262
Weintraub MichaelDirector165,116Aug 27, 20250
Gunzburg JanetPrincipal Accounting Officer34,820Jun 24, 20240
Davidoff Michael J.SVP, Payer Business73,391Jan 18, 20240
Rasmussen RandyChief Financial Officer145,594Feb 6, 20230
Pegus CherylDirector15,825Feb 23, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jan 8, 2025 (view filing)Jan 62 daysIndig ChaimChief Executive OfficerSSale−5.38K$26.61−$143.0K−0.4%1.26M after
Jan 8, 2025 (view filing)Jan 62 daysVanDuyn Amy BethSVP, Human ResourcesSSale−1.31K$26.61−$34.9K−1.1%115.6K after
Jan 8, 2025 (view filing)Jan 62 daysGandhi BalajiChief Financial OfficerSSale−3.19K$26.61−$85.0K−2.1%148.5K after
Jan 8, 2025 (view filing)Jan 6-72 daysRoberts EvanChief Operating OfficerSSale−10.2K$26.89−$274.1K−1.3%772.7K after2 lots10b5-1
Jan 10, 2025 (view filing)Jan 82 daysHui YvonnePrincipal Accounting OfficerSSale−288$28.00−$8.06K−1.1%26.9K after10b5-1
Jan 10, 2025 (view filing)Jan 82 daysRoberts EvanChief Operating OfficerSSale−2.68K$27.95−$74.9K−0.3%770.0K after2 lots10b5-1
Jan 13, 2025 (view filing)Jan 103 daysHui YvonnePrincipal Accounting OfficerSSale−388$27.85−$10.8K−1.4%26.5K after10b5-1
Jan 16, 2025 (view filing)Jan 142 daysHui YvonnePrincipal Accounting OfficerSSale−362$26.38−$9.55K−1.4%26.2K after
Jan 17, 2025 (view filing)Jan 152 daysGandhi BalajiChief Financial OfficerSSale−836$26.98−$22.6K−0.6%147.7K after
Jan 17, 2025 (view filing)Jan 152 daysRoberts EvanChief Operating OfficerSSale−1.78K$26.98−$48.2K−0.2%768.2K after
Jan 17, 2025 (view filing)Jan 152 daysLinetsky DavidSVP, Life SciencesSSale−1.95K$26.98−$52.5K−0.8%237.3K after
Jan 17, 2025 (view filing)Jan 152 daysHui YvonnePrincipal Accounting OfficerSSale−381$26.87−$10.2K−1.5%25.8K after10b5-1
Jan 17, 2025 (view filing)Jan 152 daysVanDuyn Amy BethSVP, Human ResourcesSSale−604$26.98−$16.3K−0.5%115.0K after
Jan 17, 2025 (view filing)Jan 152 daysIndig ChaimChief Executive OfficerSSale−2.99K$26.98−$80.7K−0.2%1.26M after
Jan 17, 2025 (view filing)Jan 152 daysHoffman Allison CGeneral Counsel & SecretarySSale−4.58K$26.90−$123.3K−2.9%154.6K after2 lots10b5-1
Jan 22, 2025 (view filing)Jan 211 dayIndig ChaimChief Executive OfficerSSale−21.7K$27.31−$592.4K−1.7%1.24M after
Jan 22, 2025 (view filing)Jan 211 dayLinetsky DavidSVP, Life SciencesSSale−13.9K$27.31−$378.9K−5.8%223.4K after
Jan 22, 2025 (view filing)Jan 211 dayVanDuyn Amy BethSVP, Human ResourcesSSale−4.72K$27.31−$128.9K−4.1%110.3K after
Jan 22, 2025 (view filing)Jan 211 dayRoberts EvanChief Operating OfficerSSale−12.7K$27.31−$348.2K−1.7%755.5K after
Jan 22, 2025 (view filing)Jan 211 dayHoffman Allison CGeneral Counsel & SecretarySSale−8.43K$27.31−$230.1K−5.5%146.1K after
Jan 22, 2025 (view filing)Jan 211 dayGandhi BalajiChief Financial OfficerSSale−5.83K$27.31−$159.1K−3.9%141.8K after
Jan 27, 2025 (view filing)Jan 243 daysHui YvonnePrincipal Accounting OfficerSSale−127$28.00−$3.56K−0.5%25.6K after10b5-1
Jan 29, 2025 (view filing)Jan 272 daysVanDuyn Amy BethSVP, Human ResourcesSSale−3.48K$27.47−$95.5K−2.9%114.7K after2 lots
Jan 29, 2025 (view filing)Jan 272 daysIndig ChaimChief Executive OfficerSSale−26.2K$27.47−$721.1K−2.0%1.26M after2 lots
Jan 29, 2025 (view filing)Jan 272 daysRoberts EvanChief Operating OfficerSSale−10.7K$27.47−$294.4K−1.4%764.3K after2 lots
Jan 29, 2025 (view filing)Jan 272 daysLinetsky DavidSVP, Life SciencesSSale−11.7K$27.47−$321.0K−4.8%231.3K after2 lots
Jan 29, 2025 (view filing)Jan 27-282 daysHoffman Allison CGeneral Counsel & SecretarySSale−12.8K$27.97−$357.8K−8.0%146.1K after3 lots10b5-1
Jan 29, 2025 (view filing)Jan 272 daysGandhi BalajiChief Financial OfficerSSale−4.81K$27.47−$132.2K−3.2%144.9K after2 lots
Jan 31, 2025 (view filing)Jan 292 daysLinetsky DavidSVP, Life SciencesSSale−500$29.68−$14.8K−0.2%230.8K after10b5-1
Feb 7, 2025 (view filing)Feb 52 daysLinetsky DavidSVP, Life SciencesSSale−720$29.50−$21.2K−0.3%230.1K after10b5-1
Feb 11, 2025 (view filing)Feb 74 daysLinetsky DavidSVP, Life SciencesSSale−300$29.52−$8.86K−0.1%229.8K after10b5-1
Feb 18, 2025 (view filing)Feb 135 daysLinetsky DavidSVP, Life SciencesSSale−11.6K$29.70−$345.0K−5.1%218.1K after10b5-1
Feb 18, 2025 (view filing)Feb 13-145 daysGandhi BalajiChief Financial OfficerSSale−33.6K$30.01−$1.01M−23.2%111.3K after2 lots10b5-1
Feb 18, 2025 (view filing)Feb 13-145 daysRoberts EvanChief Operating OfficerSSale−19.6K$30.02−$588.2K−2.6%744.7K after2 lots10b5-1
Feb 20, 2025 (view filing)Feb 182 daysHoffman Allison CGeneral Counsel & SecretarySSale−3.50K$29.72−$103.9K−2.4%142.6K after10b5-1
Feb 20, 2025 (view filing)Feb 18-192 daysGandhi BalajiChief Financial OfficerSSale−5.87K$30.04−$176.2K−5.3%105.4K after2 lots10b5-1
Feb 20, 2025 (view filing)Feb 18-192 daysRoberts EvanChief Operating OfficerSSale−3.70K$30.06−$111.1K−0.5%741.0K after2 lots10b5-1
Mar 19, 2025 (view filing)Mar 172 daysHoffman Allison CGeneral Counsel & SecretarySSale−3.50K$25.32−$88.5K−2.5%139.1K after10b5-1
Mar 20, 2025 (view filing)Mar 18-192 daysLinetsky DavidSVP, Life SciencesSSale−127$27.60−$3.51K−1.4%8.72K after3 lots
Mar 28, 2025 (view filing)Mar 262 daysGandhi BalajiChief Financial OfficerSSale−1.83K$27.46−$50.2K−1.7%103.6K after
Apr 10, 2025 (view filing)Apr 82 daysGandhi BalajiChief Financial OfficerSSale−8.04K$23.86−$191.9K−6.9%108.4K after2 lots
Apr 10, 2025 (view filing)Apr 8-92 daysHoffman Allison CGeneral Counsel & SecretarySSale−10.7K$23.58−$252.8K−7.2%139.1K after3 lots10b5-1
Apr 10, 2025 (view filing)Apr 8-92 daysHui YvonnePrincipal Accounting OfficerSSale−4.68K$23.48−$109.9K−15.4%25.6K after3 lots10b5-1
Apr 10, 2025 (view filing)Apr 82 daysRoberts EvanChief Operating OfficerSSale−7.23K$23.86−$172.6K−0.9%776.7K after2 lots
Apr 10, 2025 (view filing)Apr 82 daysVanDuyn Amy BethSVP, Human ResourcesSSale−1.70K$23.86−$40.4K−1.3%130.4K after2 lots
Apr 10, 2025 (view filing)Apr 82 daysIndig ChaimChief Executive OfficerSSale−12.2K$23.86−$290.3K−1.0%1.26M after2 lots
Apr 10, 2025 (view filing)Apr 82 daysLinetsky DavidSVP, Life SciencesSSale−3.94K$23.86−$94.1K−1.7%221.7K after2 lots
Apr 10, 2025 (view filing)Apr 82 daysLinetsky DavidSVP, Life SciencesSSale−248$23.85−$5.92K−2.7%9.01K after2 lots
Apr 17, 2025 (view filing)Apr 161 dayGandhi BalajiChief Financial OfficerSSale−864$23.81−$20.6K−0.8%107.5K after
Apr 17, 2025 (view filing)Apr 161 dayHoffman Allison CGeneral Counsel & SecretarySSale−1.21K$23.81−$28.9K−0.9%137.9K after